Oncology & Cancer

Perjeta approved for advanced breast cancer

(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.

Diseases, Conditions, Syndromes

Study to test new tinnitus 'treatment'

A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty 'wiring' in the brain could cure people with the debilitating hearing disorder tinnitus.

Health

Teaching about hearing can save young people's ears

Many adolescents frequently expose their ears to loud sounds, for example from portable music players. Some of them may think that 'the doctor said that my hearing is good, so I guess I can handle the loud volume'. A new ...

Medical research

US begins stem cell trial for hearing loss

US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.

Oncology & Cancer

Report: We control many breast cancer risk factors

Women concerned about breast cancer should worry less about cellphones and hair dyes and worry more about weighing or drinking too much, exercising too little, using menopause hormones and getting too much radiation from ...

page 26 from 32